Showing results (2081-2090 of 2,190) with videos related to

Sort By:
Pageof 219
Hepatology (Baltimore, Md.)|December 24, 2021
Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver diseaseNobuyoshi Kawamura, Kento Imajo, Kyle J Kalutkiewicz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 19, 2024
Longitudinal Analyses of Circulating Tumor DNA for the Detection of EGFR Mutation-Positive Advanced NSCLC Progression During Treatment: Data From FLAURA and AURA3Jhanelle E Gray, Aleksandra Markovets, Thanyanan Reungwetwattana, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 22, 2018
Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian SubsetByoung Chul Cho, Busayamas Chewaskulyong, Ki Hyeong Lee, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|August 25, 2011
Noninvasive identification of peripheral vessels of oral and maxillofacial regions by using electrocardiography-triggered three-dimensional fast asymmetric spin-echo sequencesTatsurou Tanaka, Masafumi Oda, Shinji Kito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancerH Yoshioka, N Katakami, H Okamoto, et al.
The New England Journal of Medicine|June 5, 2018
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLCMark A Socinski, Robert M Jotte, Federico Cappuzzo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 3, 2016
A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitorsY Shinkoda, A Shirahata, K Fukutake, et al.
Pageof 219